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Innate immune cell activation via Toll-like re-
ceptors induces the release of infl  ammatory cy-
tokines, chemokines, and mediators. A rapid 
and robust response of macrophages and den-
dritic cells is needed for the control and elim-
ination of fast-growing microbial invaders. 
Nevertheless, the intensity and duration of this 
response have to be limited to avoid excessive 
infl  ammatory tissue damage. A range of regula-
tory factors acts at multiple levels to restrict or 
down-regulate the cytokines released from ac-
tivated macrophages. These include the inhib-
itory cytokines IL-10 and TGF-β; cytokine 
antagonists, such as IL-1Rn and IL-18 bind-
ing protein; intracellular modulators of signal-
ing  pathways, such as the phosphatase SHIP 
(1); members of the suppressor of cytokine sig-
naling protein family (2); and transcriptional 
regulators, such as c-maf (3) and Bcl-3 (4). Func-
tionally, LPS-triggered activation of macro-
phages induces a state of refractoriness to further 
stimulation, a process termed LPS tolerance 
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that is incompletely understood but may in-
volve one or the other of the above-mentioned 
molecular players (5).
TLR signaling via Myd88 activates two ma-
jor pathways linking the cell surface to tran-
scriptional activation in the nucleus: besides 
  release of Rel proteins from IκB for nuclear 
translocation, the mitogen-activated protein 
kinase (MAPK) cascade is activated and p38, 
ERK1/2, and JNK are all activated through 
phosphorylation by their respective upstream 
kinase (for review see reference 6). The termi-
nation of MAPK activity by endogenous reg-
ulators is evident from the transient kinetics 
of TLR-induced phosphorylation that, depen-
dent on the cell type and experimental con-
ditions used, returns to base levels after one to 
several hours. During the last decade, a family 
of dual specifi  city phosphatases (DUSPs) was 
identifi  ed that acts as MAPK phosphatases by 
binding to activated MAPKs and dephosphor-
ylating them at threonine and tyrosine residues. 
The prototypic member of this family, DUSP1 
(also known as mkp-1, erp, Ptpn16, and 3CH134), 
<doi> 10.1084/jem.20051753 </doi><aid>20051753</aid>Dual specifi  city phosphatase 1 (DUSP1) 
regulates a subset of LPS-induced genes and 
protects mice from lethal endotoxin shock
Michael Hammer,1 Jörg Mages,1 Harald Dietrich,1 Angela Servatius,1 
Norma Howells,2 Andrew C.B. Cato,2 and Roland Lang1
1Institute of Medical Microbiology, Immunology, and Hygiene, Technical University Munich, 81675 Munich, Germany
2Forschungszentrum Karlsruhe Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany
Activation of the mitogen-activated protein kinase (MAPK) cascade after Toll-like receptor 
stimulation enables innate immune cells to rapidly activate cytokine gene expression. A 
balanced response to signals of infectious danger requires that cellular activation is tran-
sient. Here, we identify the MAPK phosphatase dual specifi  city phosphatase 1 (DUSP1) as 
an essential endogenous regulator of the infl  ammatory response to lipopolysaccharide 
(LPS). DUSP1-defi  cient (DUSP1−/−) bone marrow–derived macrophages showed selectively 
prolonged activation of p38 MAPK and increased cytokine production. Intraperitoneal 
challenge of DUSP1−/− mice with LPS caused increased lethality and overshooting produc-
tion of interleukin (IL)-6 and tumor necrosis factor 𝗂. Transcriptional profi  ling revealed 
that DUSP1 controls a signifi  cant fraction of LPS-induced genes, which includes IL-6 and 
IL-10 as well as the chemokines CCL3, CCL4, and CXCL2. In contrast, the expression of the 
important mediators of endotoxin lethality, interferon 𝗄 and IL-12, was not signifi  cantly 
altered by the absence of DUSP1. These data together demonstrate a specifi  c regulatory 
role of DUSP1 in controlling a subset of LPS-induced genes that determines the outcome 
of endotoxin shock.
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was identifi  ed as an immediate early gene in serum-stimu-
lated fi  broblast (7) but is expressed in many cell types in re-
sponse to growth factors, stress, or heat shock (for review see 
reference 8). In macrophages, DUSP1 expression is increased 
upon stim  ulation with LPS or peptidoglycan (9, 10), but also 
by dexamethasone (11). We recently found that IL-10 increases 
DUSP1 expression in activated macrophages (12). Using 
DUSP1−/− embryonic fi  broblasts and alveolar macrophages, 
it was shown that DUSP1 defi  ciency results in prolonged ac-
tivation of p38 MAPK (11, 13).
We have used DUSP1−/− mice (14) to investigate the re-
quirement of DUSP1 for regulation of the innate immune 
response to LPS in vivo. Our data indicate that DUSP1 reg-
ulates a subset of LPS-induced genes, whose overproduction 
in DUSP1−/− mice is suffi   cient to cause 100% lethality after 
injection of a normally sublethal dose of LPS. These fi  ndings 
point to a nonredundant role of DUSP1 in balancing innate 
immune responses and suggest more specifi  c functions of the 
diff  erent DUSPs than previously anticipated.
RESULTS AND DISCUSSION
LPS-induced IL-6 production and MAPK activation in 
DUSP1−/− macrophages
Using primary bone marrow–derived macrophages from 
WT and DUSP1−/− mice, we observed signifi  cantly higher 
production of IL-6 in response to titrated amounts of LPS 
(Fig. 1 A). The secretion of TNF-α by LPS-stimulated 
  macrophages was less aff   ected by DUSP1 defi  ciency  but 
higher than in WT (not depicted). These data confi  rm and 
extend the recently reported increase in TNF-α production 
in DUSP1−/− alveolar macrophages (11) and demonstrate 
diff  erential control of various cytokines by DUSP1. In a 
  kinetic analysis of MAPK phosphorylation, we found pri-
marily an eff  ect of DUSP1 defi  ciency on the down-regu-
lation of p38 activation that led to markedly increased 
phospho-p38 levels at later time points (Fig. 1 B). In con-
trast, the kinetics of ERK1/2 activation were similar in 
WT and DUSP1−/− macrophages, whereas JNK showed a 
transiently increased phosphorylation status in the absence 
of DUSP1. Thus, DUSP1 is essential for the control of p38 
activation in LPS-activated macrophages, which is consis-
tent with earlier data showing selectivity of this MAPK 
phosphatase for p38 over ERK1/2 (15) and corroborates 
data by Zhao et al. (11) that demonstrate prolonged p38 ac-
tivation in DUSP1−/− alveolar macrophages. In addition to 
DUSP1, LPS induces DUSP2, DUSP10, and DUSP16 in 
macrophages (12, 16, 17); apparently, however, these can-
not fully compensate for a lack of DUSP1 in terms of p38 
regulation, but may be more eff  ective in regulating JNK and 
ERK1/2 activity.
Increased susceptibility of DUSP1−/− mice to lethal 
LPS shock
Based on these in vitro data, we asked whether DUSP1 de-
termines the response to LPS in vivo. First, we observed that 
after i.p. injection of LPS, DUSP1 mRNA expression was 
induced rapidly in the spleen (Fig. 2 A), lung, and liver (not 
depicted). To test the hypothesis that induction of DUSP1 
expression is required to limit the infl  ammatory response in 
a negative feedback loop, we used DUSP1−/− mice in a 
high-dose LPS shock model (Fig. 2 B). At an LPS dose of 
25   mg/kg body weight, all the injected DUSP1−/− mice 
died between 20 and 48 h thereafter. In contrast, >90% of 
WT mice survived.
Cytokine production in vivo
Serum levels of cytokines with a known role in the patho-
genesis of endotoxin shock were analyzed to investigate the 
mechanism underlying the high susceptibility to LPS in the 
absence of DUSP1 (Fig. 2 C). Already 1.5 h after injection 
of LPS, the levels of TNF-α and IL-6 were signifi  cantly ele-
vated in DUSP1−/−. At the later time points, diff  erences 
were even more pronounced for IL-6, whereas TNF-α was 
down-regulated in the DUSP1−/−, although still higher than 
in WT (Fig. 2 C). Because DUSP1−/− and WT mice were 
on a mixed background, we confi  rmed the diff  erences in 
IL-6 and TNF-α levels 6 h after LPS injection in mice back-
crossed on pure backgrounds to exclude confounding by 
modifi  er genes (Fig. 2 C, right). We also analyzed IFN-γ 
and IL-12p40, both known to contribute to lethal outcome 
of endotoxin shock (18–20), and found no signifi  cant eff  ect 
of DUSP1 defi  ciency 6 h after injection (Fig. 2 D; not de-
picted for IFN-γ). In contrast, IL-10−/− mice that are also 
highly susceptible to LPS shock (21) exhibited uncontrolled 
Figure 1.  In vitro analysis of macrophages from DUSP1−/− mice. 
(A) Production of IL-6 from LPS-treated macrophages was analyzed by 
ELISA in supernatants harvested 8 h after stimulation. The mean and 
standard deviations of triplicate measurements from a representative 
experiment are shown. (B) Kinetics of MAPK activation by 100 ng/ml LPS 
in macrophages generated from bone marrow cells of DUSP1+/− or 
DUSP1−/− mice. 1.5 × 106 cells were stimulated for the indicated times, 
and whole cell lysates were analyzed by Western blot using antibodies 
to phosphorylated p38, ERK1/2, JNK, and to γ-tubulin at a 1:1,000 
  dilution. Data shown are from one representative experiment out of 
three performed.JEM VOL. 203, January 23, 2006  17
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release of IFN-γ, IL-12, IL-6, and TNF-α (Fig. 2 D and 
reference 21).
Genome-wide analysis of DUSP1-regulated gene expression 
in LPS-challenged mice
To obtain a global view of the impact DUSP1 has on 
LPS-induced gene expression, transcriptional profi  ling was 
performed using spleen RNA prepared 6 h after LPS chal-
lenge. In both groups of mice, LPS induced substantial 
changes in gene expression, with a considerable overlap in 
the genes induced in WT or DUSP1−/− mice (Fig. 3 A, 
Venn diagram; see Table S1, available at http://www.jem.
org/cgi/content/full/jem.20051753/DC1, for a complete 
list of 608 up-regulated genes). However, in DUSP1−/− 
mice, nearly threefold more genes were uniquely up-regu-
lated compared with WT, which is also evident from the 
hierarchical clustering analysis, with cluster C containing 
229 genes induced more strongly in the absence of DUSP1 
(Fig. 3 A; see also box plots for the various clusters in 
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20051753/DC1). The microarray data corroborate most 
of the cytokine data obtained by ELISA from serum sam-
ples. IL-6 was up-regulated in DUSP1−/− mice, whereas 
IL-12p40 and IFN-γ showed no diff  erence in expression. 
A notable exception is TNF-α, whose expression was not 
increased in DUSP1−/− mice at the mRNA level, a result 
that was confi  rmed by Northern analysis (Fig. S2) and likely 
due to posttranscriptional eff  ects (e.g., on mRNA stability 
or translation).
Control of selected infl  ammatory molecules by DUSP1
We mined the microarray data with regard to the question of 
how DUSP1 defi  ciency causes excess lethality in LPS chal-
lenge. Although some downstream eff  ectors of LPS-induced 
lethality may not yet be expressed at the relatively early time 
point analyzed in this experiment, DUSP1−/− mice already 
appeared sicker clinically. Therefore, it seems reasonable to 
assume a contribution to the severe infl  ammatory response 
for at least some of the genes overexpressed in the absence of 
DUSP1. Among the cytokines that have been implicated as 
Figure 2.  DUSP1 is induced after injection of LPS and controls 
survival and cytokine production. (A) Expression levels of DUSP1 in 
the spleens of WT mice were determined at the indicated times after 
injection of 10 mg/kg LPS i.p. by Northern blot analysis of 10 µg total 
RNA. Data shown are from individual mice (n = 3–4) from one represen-
tative experiment. (B) Survival of WT (n = 15) and DUSP1−/− mice 
(n = 13) after i.p. injection of 25 mg/kg LPS. Data are pooled from two 
experiments. (C and D) Serum levels of cytokines after LPS injection 
(10 mg/kg). Data shown are the mean and standard deviation (n = 3–4 
mice per data point) from representative experiments. Two data points 
marked by asterisks were beyond the maximum of the standard curve, 
and the   upper limits of the dynamic range of the assay are shown. 
(C) TNF-α and IL-6 in WT and DUSP1−/− mice on a mixed 129Sv × Bl/6 
(left) or pure 129Sv and C3H (right) background (6 h after LPS). 
(D) Comparison of the effect of defi  ciency in DUSP1 or IL-10 on serum 
levels of TNF-α and IL-12p40.18  DUSP1 FUNCTION IN LPS SHOCK | Hammer et al.
contributors to the pathogenesis of lethal endotoxin shock, 
IFNs type I and II as well as IL-12, TNF- α, IL-1α, and 
IL-18 were expressed at similar levels in WT and DUSP1−/− 
spleen (Table S2). On the other hand, the chemokines CCL3, 
CCL4, and CXCL2 were among the LPS targets overex-
pressed most strongly in DUSP1−/− spleens, a fi  nding that 
was validated at the protein level by corresponding serum 
levels (Fig. 3 B), and may contribute to the development of 
shock. For example, CCL3 (MIP-1α) promotes leukocyte 
recruitment to the lungs and increases lethality (22), an eff  ect 
that may be enhanced by the closely related CCL4 (MIP-1β) 
and CXCL2 (MIP-2). In contrast, CXCL10 (IP-10) was not 
aff  ected by the absence of DUSP1 at the mRNA or protein 
level (Fig. 3 B).
The production of IL-10 is regulated by DUSP1
The microarray analysis identifi  ed the immunoregulatory cy-
tokine IL-10 to be induced 3.3-fold stronger in the DUSP1−/− 
spleen, which was confi  rmed by Northern blotting (Fig. 3 
C). This diff  erence was strikingly more pronounced in the 
liver, which may account for the 10-fold higher serum IL-
10 levels in DUSP1−/− compared with WT mice 6 and 20 h 
after LPS challenge (Fig. 3 C). Higher production of IL-10 in 
response to LPS was also observed in DUSP1−/− macro-
phages stimulated in vitro (not depicted). Among the genes 
overexpressed in DUSP1−/− spleens, we observed a consid-
erable number of transcripts previously identifi  ed as IL-10–
induced genes (23), including SOCS3, NFIL3, Ndr1, and 
Gadd45γ (Table S1), probably refl  ecting secondary eff  ects of 
Figure 3.  Genome-wide analysis of LPS-induced gene expression 
in the spleens of WT and DUSP1−/− mice. (A) Total splenic RNA was 
prepared from control WT and DUSP1−/− mice 6 h after i.p. injection of 
10 mg/kg LPS (n = 3 per group) and was processed for Affymetrix 
GeneChip analysis. Venn diagram comparing the numbers of genes sig-
nifi  cantly up-regulated in WT and DUSP1−/− mice by LPS (for criteria see 
Materials and methods). Z-score–normalized expression values of LPS-
induced genes were subjected to hierarchical clustering analysis. Cluster 
A contains a group of genes expressed more strongly in the WT spleen. 
In contrast, cluster C represents a larger subset of LPS-induced genes 
up-regulated in the absence of DUSP1. Expression data of these 608 
genes can be found in Table S1. (B) Differential control of the chemo-
kines CCL3, CCL4, CXCl2, and CXCL10 by DUSP1. Confi  rmation of the 
microarray expression data (left: average and standard deviation of 
  signal intensity values) by ELISA determination of serum levels (right: 
mean and standard deviation, n = 3–4). (C) Increased expression of IL-10 
at the mRNA and protein level in DUSP1−/− mice. Northern data from 
two and three individual mice per condition and organ are shown, and 
ELISA data are the mean and standard deviation (n = 3–4) from a 
 representative  experiment.JEM VOL. 203, January 23, 2006  19
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the overshooting production of IL-10 and IL-6 that both ac-
tivate transcription via Stat3 signaling. However, high IL-10 
levels in DUSP1−/− mice were not eff  ective in down-regu-
lating synthesis of IL-6 or the chemokines CCL3, CCL4, or 
CXCL2 (Fig. 3 B). Thus, DUSP1 may be required for inhi-
bition of at least some IL-10–regulated genes.
Concluding remarks
The fi  nding of a nonredundant role for DUSP1 in balancing 
the infl  ammatory response suggests that the various members 
of the DUSP family of MAPK phosphatases fulfi  ll specifi  c 
regulatory roles in innate immune cells. The recent report of 
increased JNK activation in innate and adaptive immune cells 
in the absence of DUSP10 is another example of this appar-
ent division of labor between diff  erent MAPK phosphatases 
(17). In the case of DUSP1, the p38 MAPK pathway likely 
is the major target, and DUSP1 defi  ciency unleashes the ex-
pression of a rather selective set of TLR-induced genes that 
can be hypothesized to be direct or indirect targets of p38 
MAPK. However, it is also possible that in addition to the 
various MAPKs, DUSP1 dephosphorylates other substrates 
as well. Surprisingly, the lethal outcome of LPS challenge in 
DUSP1−/− is correlated with excessive production of the anti-
infl  ammatory cytokine IL-10. This counterintuitive fi  nding 
may indicate that important inhibitory eff  ects of IL-10 on 
  infl  ammation depend on DUSP1 function. Similarly, in the 
myeloid-specifi  c Stat3-defi  cient mouse, abrogated IL-10 sig-
naling leads to overshooting, lethal cytokine production that 
includes IL-10 (24). Given the phenotype of DUSP1−/− 
mice in the high-dose LPS model reported here, it will be 
interesting to investigate the contribution of this phosphatase 
to the host response in models of infection and polymicrobial 
sepsis. Finally, the DUSP family emerges as a potential target 
for immunomodulation; identifi  cation of small molecule in-
hibitors has recently been reported (25, 26) and holds prom-
ise for selective therapeutic intervention.
MATERIALS AND METHODS
Mice, cells, and reagents. DUSP1−/− blastocysts generated by the 
R. Bravo laboratory at Bristol-Myers Squibb Pharmaceutical Research Insti-
tute (14) were supplied by The Jackson Laboratory and subsequently bred on 
a mixed 129Sv × C57BL/6 background at the Forschungszentrum Karl-
sruhe. All experiments were performed according to European and German 
statutory regulations and approved by the Regierung von Oberbayern. The 
genotype of the mice was established by tissue biopsies and subsequent DNA 
analysis by PCR using two separate reactions with the allele-specifi  c primers 
5′-C  A  G  G  T  A  C  T  G  T  G  T  G  T  C  G  G  T  G  G  T  G  C  T  A  A  T  G  -3′ (WT) and 5′-A  A  A-
T  G  T  G  T  C  A  G  T  T  T  C  A  T  A  G  C  C  T  G  A  A  G  A  A  C  G  -3′ (mutant), which were 
used with the common reverse primer 5′-C  T  A  T  A  T  C  C  T  C  C  T  G  G  C  A  C  A  A-
T  C  C  T  C  C  T  A  G  -3′, respectively.
For control experiments, mice backcrossed for seven generations onto 
C3H and 129Sv were used. Mice were used for LPS challenge at an age of 
5–10 wk. Experimental groups were matched for age and sex. Escherichia coli 
O55:B5 LPS (no. L2880; Sigma-Aldrich) was diluted in sterile PBS and in-
jected i.p. Bone marrow–derived macrophages were diff  erentiated for 5–7 d 
in M-CSF containing media as described previously (27).
Detection of cytokines by ELISA. Serum and cell culture supernatants 
were analyzed for cytokine content using Duoset antibody pairs (R&D 
  Systems) for detection of IL-6, TNF-α, IFN-γ, CXCL10, and IL-10. IL-
12p40 production was measured with an OptiEIA kit from BD Biosciences, 
and CXCL2, CCL3, and CCL4 were measured with Quantikine kits from 
R&D Systems.
Analysis of MAPK activation by immunoblotting. Bone marrow–
  derived macrophages were treated as indicated and processed for analysis by 
Western blot as described previously (27). Antibodies for phosphorylated 
and total p38, JNK, and ERK1/2 were from Cell Signaling, and anti–γ-
  tubulin antibody was from Sigma-Aldrich and used at a 1:1,000 dilution.
Microarray analysis of gene expression. Total spleen RNA (5 µg) was 
  labeled and hybridized to Aff  ymetrix MOE430A 2.0 GeneChips according to 
the manufacturer’s instructions. Three biological replicates per condition were 
analyzed. CEL fi  les were processed for global normalization and generation of 
expression values using the rma algorithm in the R aff  y package (http://www. 
bioconductor.org). Normalized CEL expression values deposited in the Gene 
Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) as series GSE3565.
The list of signifi  cantly regulated genes was achieved by applying the SAM 
multiclass algorithm (28) of the samr package for R (FDR < 1%: 1,465 probe 
sets). Further fi  ltering included a minimum fold-change criterion between all 
four experimental conditions of ±2 (1,372 probe sets) and a max (all mean ex-
pression values) − min (all mean expression values) fi  lter of >50 (1,215 probe 
sets). Of these, 608 were up-regulated. Further data preparation was performed 
with the Spotfi  re DecisionSite software (Spotfi  re), and hierarchical clustering 
was performed using the program Genesis (release 1.1.3; reference 29).
Northern blot analysis of mRNA expression. Northern blot analysis 
was performed as described previously (23) using cDNA probes obtained 
from Deutsches Ressourcenzentrum für Genomforschung.
Online supplemental material. A list of all 608 genes that were found 
up-regulated by microarray analysis in WT or DUSP1−/− spleen 6 h after 
LPS injection can be found in Table S1. The expression levels of cytokines, 
chemokines, and ILs, as well as their receptors, in this microarray dataset are 
depicted in Table S2. Marked in bold are the probe sets showing signifi  cant 
diff  erences in expression between WT and DUSP1−/− mice after LPS chal-
lenge with a p-value of <0.01. Fig. S1 shows box plots complementing the 
microarray data from Fig. 3 A. Fig. S2 contains Northern blot validations of 
microarray results. Supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20051753/DC1.
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